seed
Stage
2
Investors
About
hC Bioscience is developing a new class of RNA therapeutics to correct disease-causing protein errors. Their proprietary technology platform aims to treat a wide range of genetic diseases by precisely correcting protein errors at the ribosomal level.
Explore hC Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.